Skip to Content

Insulin Detemir

In the US, Insulin Detemir (insulin detemir systemic) is a member of the drug class insulin and is used to treat Diabetes - Type 1 and Diabetes - Type 2.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10AE05

CAS registry number (Chemical Abstracts Service)

0169148-63-4

Chemical Formula

C267-H402-N64-O76-S6

Molecular Weight

5916

Therapeutic Categories

Antidiabetic agent

Insulin analogue, recombinant human

Chemical Names

29B-(N⁶-myristoyl-L-lysine)-30B-de-L-treonineinsulin (human) (WHO)

29B-[N⁶-(1-Oxo-tetradecyl)-L-lysine]-(1A-21A),(1B-29B)-insulin (human) (USAN)

Des-30B-L-treonine-29B-(N⁶-myristoyl-L-lysine)human insulin (BAN)

Foreign Names

  • Insulinum detemirum (Latin)
  • Insulin detemir (German)
  • Insulin détémir (French)
  • Insulina detemir (Spanish)

Generic Names

Brand Names

  • Levemir
    Laboratorio Novo Nordisk, Chile; Novo Nordisk, Austria; Novo Nordisk, Australia; Novo Nordisk, Bosnia & Herzegowina; Novo Nordisk, Bangladesh; Novo Nordisk, Belgium; Novo Nordisk, Canada; Novo Nordisk, Switzerland; Novo Nordisk, China; Novo Nordisk, Czech Republic; Novo Nordisk, Germany; Novo Nordisk, Denmark; Novo Nordisk, Egypt; Novo Nordisk, Spain; Novo Nordisk, Finland; Novo Nordisk, France; Novo Nordisk, United Kingdom; Novo Nordisk, Georgia; Novo Nordisk, Greece; Novo Nordisk, Hong Kong; Novo Nordisk, Croatia (Hrvatska); Novo Nordisk, Hungary; Novo Nordisk, Indonesia; Novo Nordisk, Ireland; Novo Nordisk, Israel; Novo Nordisk, Iceland; Novo Nordisk, Italy; Novo Nordisk, Japan; Novo Nordisk, South Korea; Novo Nordisk, Lithuania; Novo Nordisk, Latvia; Novo Nordisk, Mexico; Novo Nordisk, Malaysia; Novo Nordisk, Netherlands; Novo Nordisk, Norway; Novo Nordisk, New Zealand; Novo Nordisk, Oman; Novo Nordisk, Philippines; Novo Nordisk, Poland; Novo Nordisk, Portugal; Novo Nordisk, Romania; Novo Nordisk, Serbia; Novo Nordisk, Russian Federation; Novo Nordisk, Sweden; Novo Nordisk, Slovakia; Novo Nordisk, Thailand; Novo Nordisk, Tunisia; Novo Nordisk, Turkey; Novo Nordisk, Taiwan; Novo Nordisk, United States; Novo Nordisk, Vietnam; Novo Nordisk, South Africa; Wael, Bahrain

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide